Founded by an elite team of dedicated immunoassay research scientists in Canada in 2002, Artron has been one of the leading IVD solution providers with the capacity to successfully integrate a full industry stream from raw materials R&D, manufacturing, sales and marketing to technical support over the past two decades. To help more people live healthier lives, Artron offers a broad range of immunoassay detection systems and solutions with high sensitivity and quick response time through our global sales networks covering over 120 countries and regions. Our featured products are certified by various regulatory authorities such as Health Canada, WHO, FDA, CE, etc. The portfolio includes Fertility, Infectious Diseases, Tumour Markers, Cardiac Markers, Food Safety, GMOs, Drugs of Abuse, etc. Headquartered in the Great Vancouver area, Canada, Artron possesses a number of global facilities and laboratories with a total area of over 200000 square feet to streamline its operations. The facilities and the quality management systems are in full compliance with ISO 13485:2016 and are certified by MDSAP (Medical Device Single Audit Program). Artron’s reputation as a prominent and reliable immunoassay detection product provider was further recognized and endorsed by the winning bids in the Canadian government as well as the Egyptian government’s procurement of rapid test products in recent years. Our initiatives of scientific innovations that enable Artron’s continuous organic growth are identified and supported financially by the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP).